Corporate finance and strategic transactions specialist with experience advising growth-stage healthcare and technology companies and investors. Melissa S. Kampmann combines operational leadership and M&A execution, having managed cross-border deals, capital raises and integrations while partnering with PE and venture investors. Market-facing skills include financial modelling, commercial diligence and board-level communications. Regularly engages on exit planning, corporate development and investor relations for founder-led businesses.
Corporate finance and strategic transactions specialist with experience advising growth-stage healthcare and technology companies and investors. Melissa S. Kampmann combines operational leadership and M&A execution, having managed cross-border deals, capital raises and integrations while partnering with PE and venture investors. Market-facing skills include financial modelling, commercial diligence and board-level communications. Regularly engages on exit planning, corporate development and investor relations for founder-led businesses.
Prioritizes disciplined, growth‑oriented capital allocation in healthcare and technology, favoring scalable, founder-led businesses where strategic corporate development and operational improvements unlock value. Emphasizes rigorous financial modelling, commercial diligence and deal structuring to align incentives across founders, PE and venture partners. Prefers cross‑border opportunities with clear exit pathways, active board engagement and integration plans; balances conviction bets with portfolio-level risk controls and milestone‑driven capital deployment.
Prioritizes disciplined, growth‑oriented capital allocation in healthcare and technology, favoring scalable, founder-led businesses where strategic corporate development and operational improvements unlock value. Emphasizes rigorous financial modelling, commercial diligence and deal structuring to align incentives across founders, PE and venture partners. Prefers cross‑border opportunities with clear exit pathways, active board engagement and integration plans; balances conviction bets with portfolio-level risk controls and milestone‑driven capital deployment.
| Trades 377 | Longs Won 247/377 65% | Profit Factor 5.94 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $529,175.38 |
| Average Win $233,825.48 | Best Trade (Jul 16) $5.5M | Sharpe Ratio -8.97 |
| Average Loss -$74,776.19 | Worst Trade (Dec 30) -$983,883.55 | Z-Score -3.29 (100%) |
| Commissions $0 | Avg. Trade Length 9m 1w 6d | Expectancy $59,544.93 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.22% |
| Consecutive Losing Trades | 1,821 | 1,639 | 1,457 | 1,275 | 1,093 | 911 | 729 | 546 | 364 | 182 |